First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process.

@article{MeloMartn2015FirstinhumanCT,
  title={First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process.},
  author={Inmaculada de Melo-Mart{\'i}n and Natalie Hellmers and Claire Henchcliffe},
  journal={Parkinsonism & related disorders},
  year={2015},
  volume={21 8},
  pages={
          829-32
        }
}
First-in-human clinical trials of innovative medical procedures, such as cell transplantation for Parkinson's disease, present a variety of ethical challenges. In an era of rapidly developing stem cell technologies likely to be translated into clinical trials over the next few years, it is critical that ethical concerns be fully considered. One important undertaking is ensuring that research participants give free and truly informed consent. This will necessitate adequate disclosure of risks… CONTINUE READING
BETA

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 45 REFERENCES

Stem cell therapies for Parkinson ' s disease : are trials just around the corner ?

  • R. A. Barker Drouin-Ouellet
  • Regen . Med .
  • 2014

A

  • M. Sundberg, H. Bogetofte, T. Lawson, J. Jansson, G. Smith
  • Astradsson, et al., Improved cell therapy…
  • 2013

I

  • R. A. Barker
  • de Beaufort, Scientific and ethical issues…
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…